OS 32-04 ACUTE BLOOD PRESSURE CONTROL BY RENAL DENERVATION IMPROVED PROGNOSIS AFTER CEREBRAL INFARCTION THROUGH REDUCTION OF OXIDATIVE STRESS IN SHRSP RATS

2016 ◽  
Vol 34 (Supplement 1) ◽  
pp. e390-e391
Author(s):  
Yu Hasegawa ◽  
Shokei Kim-Mitsuyama
2021 ◽  
Vol 128 (7) ◽  
pp. 1080-1099
Author(s):  
Felix Mahfoud ◽  
Markus P. Schlaich ◽  
Melvin D. Lobo

In the past decade, efforts to improve blood pressure control have looked beyond conventional approaches of lifestyle modification and drug therapy to embrace interventional therapies. Based upon animal and human studies clearly demonstrating a key role for the sympathetic nervous system in the etiology of hypertension, the newer technologies that have emerged are predominantly aimed at neuromodulation of peripheral nervous system targets. These include renal denervation, baroreflex activation therapy, endovascular baroreflex amplification therapy, carotid body ablation, and pacemaker-mediated programmable hypertension control. Of these, renal denervation is the most mature, and with a recent series of proof-of-concept trials demonstrating the safety and efficacy of radiofrequency and more recently ultrasound-based renal denervation, this technology is poised to become available as a viable treatment option for hypertension in the foreseeable future. With regard to baroreflex activation therapy, endovascular baroreflex amplification, carotid body ablation, and programmable hypertension control, these are developing technologies for which more human data are required. Importantly, central nervous system control of the circulation remains a poorly understood yet vital component of the hypertension pathway and mandates further investigation. Technology to improve blood pressure control through deep brain stimulation of key cardiovascular control territories is, therefore, of interest. Furthermore, alternative nonsympathomodulatory intervention targeting the hemodynamics of the circulation may also be worth exploring for patients in whom sympathetic drive is less relevant to hypertension perpetuation. Herein, we review the aforementioned technologies with an emphasis on the preclinical data that underpin their rationale and the human evidence that supports their use.


Physiology ◽  
2019 ◽  
Vol 34 (3) ◽  
pp. 178-188 ◽  
Author(s):  
Jane F. Reckelhoff ◽  
Damian G. Romero ◽  
Licy L. Yanes Cardozo

One of the mechanisms responsible for blood pressure (BP) regulation is thought to be oxidative stress. In this review, we highlight preclinical studies that strongly support a role for oxidative stress in development and maintenance of hypertension in male animals, based on depressor responses to antioxidants, particularly tempol and apocynin. In females, oxidative stress seems to be important in the initial development of hypertension. However, whether maintenance of hypertension in females is mediated by oxidative stress is not clear. In clinical studies, pharmacological intervention to reduce BP with antioxidants has conflicting results, mostly negative. This review will discuss the uncertainties regarding blood pressure control and oxidative stress and potential reasons for these outcomes.


Author(s):  
Costas Tsioufis ◽  
Kyriakos Dimitriadis ◽  
Athanasios Kordalis ◽  
Michalis Doumas ◽  
Dimitris Konstantinidis ◽  
...  

2007 ◽  
Vol 34 (9) ◽  
pp. 938-945 ◽  
Author(s):  
Julio C Sartori-Valinotti ◽  
Radu Iliescu ◽  
Lourdes A Fortepiani ◽  
Licy L Yanes ◽  
Jane F Reckelhoff

Sign in / Sign up

Export Citation Format

Share Document